Clinical Trials
17 trialsNCT07626021 2026-06-04
Selinexor Monotherapy for Cytoreduction in BCR::ABL1-Negative Myeloproliferative Neoplasms
Zhongshan Hospital (Xiamen), Fudan University
Phase 2 Not yet recruiting
NCT07572929 2026-05-07
PREeMPT
Medical College of Wisconsin
Phase 2 Not yet recruiting
NCT07468916 2026-05-06
Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Jonsson Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT07528417 2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2 Not yet recruiting
NCT07518940 2026-04-09
ENERGIA
University of Turin, Italy
Phase NA Not yet recruiting
NCT05969821 2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT07387354 2026-03-16
MDS
Thomas Jefferson University
Phase 1/2 Not yet recruiting
NCT07384039 2026-02-05
MPN-Exercise
Hannover Medical School
Phase NA Not yet recruiting
NCT07349134 2026-01-20
WELL-MPN
Brigham and Women's Hospital
Phase NA Not yet recruiting
NCT07249840 2025-11-25
Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Brigham and Women's Hospital
Phase 1 Not yet recruiting
NCT07108023 2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
NCT06290765 2025-07-31
PV
PharmaEssentia
Phase 4 Not yet recruiting
NCT06753279 2024-12-31
Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)
Assiut University
Not yet recruiting
NCT06647706 2024-10-18
Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.
Assiut University
Not yet recruiting
NCT06334913 2024-03-28
A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms
Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting
NCT06022341 2023-09-01
MOZART
University Hospital, Angers
Phase NA Not yet recruiting
NCT04451200 2020-11-17
BUSEQ
Institut Paoli-Calmettes
Phase 2 Not yet recruiting